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Abstract  
Purpose  
To assess avoidable waste in ophthalmic epidemiology by examining the availability of information 
from blindness prevalence surveys undertaken in low and middle income countries (LMICs) between 
2000 and 2014.  
Methods  
On December 1 2016 we searched MEDLINE, EMBASE and Web of Science databases for cross-
sectional blindness prevalence surveys undertaken in LMICs between 2000–2014. All surveys listed 
on the RAAB Repository website were also considered. For each survey we assessed i) availability 
of scientific publication, survey report, summary results tables and/or datasets; ii) time to publication 
and journal attributes; iii) variability in blindness definitions; and iv) rigour when information was 
available from more than one source. 
Results  
Of the 279 included surveys (from 68 countries) 186 (67%) used RAAB methodology; 146 (52%) 
were published in a scientific journal, 57 (20%) were published in a journal and on the RAAB 
repository, and 76 (27%) were on the Repository only (8% had tables; 19% had no information 
available beyond registration). Datasets were available for 50 RAABs (18% of included surveys). 
Time to publication ranged from <1–11 years (mean, standard deviation 2.8±1.8 years). The extent 
of blindness definitions reported within studies varied; those with both a published report and RAAB 
Repository tables were most complete. Discrepancies were found in participant numbers (14%) and 
blindness prevalence (15%) reported in publications and RAAB tables of the same survey.  
Conclusion 
Strategies are needed to improve the availability, consistency and quality of information reported 
from blindness prevalence surveys, and hence reduce avoidable waste. 
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Introduction 
Good quality evidence is required to achieve the ambitious goal of universal eye health set by the 
World Health Assembly in 2013.1 This evidence includes data from prevalence surveys on the 
magnitude and causes of visual impairment and blindness. Over the past two decades an increasing 
number of prevalence surveys have been undertaken, especially in low and middle income countries 
(LMICs). The current global eye health action plan of the World Health Organization (WHO) calls for 
more prevalence surveys to be undertaken to provide up-to-date local evidence for planning.2 
 
An important factor in the recent increase in blindness prevalence surveys is the development of a 
protocol and software that can be downloaded freely from the internet3—the Rapid Assessment of 
Avoidable Blindness (RAAB) and its predecessor the Rapid Assessment of Cataract Surgical 
Services (RACSS, hereafter collectively referred to as RAAB). RAAB is a population based survey of 
visual impairment in people aged 50 years and above that correlated well with data from total 
population surveys.4 Because RAAB surveys are restricted to those aged 50 years and above, 
where blindness prevalence is highest,4 the sample size is smaller, and the survey is shorter and 
less expensive than traditional surveys.5 RAAB uses simple examination methods, and the software 
includes a data entry and automated analysis package.  
 
A consequence of the increasing number of blindness prevalence surveys is a reluctance by editors 
of scientific journals to publish them, as they offer little novelty in terms of purpose or methodology.6 
In this publishing environment the online RAAB Repository7 has played an important role in 
dissemination of survey findings. The Repository was launched in May 2014 and by December 1 
2016 the webmaster (HL) had registered 266 RAABs on the Repository.  
 
In 2009 Chalmers and Glasziou highlighted the issue of “avoidable waste” in the production and 
reporting of health research.8 In the context of ophthalmic epidemiology, sources of avoidable waste 
include duplication of effort (i.e. numerous surveys in the same area); and survey reports remaining 
unpublished, gaining publication after a long delay, or being incomplete or of poor quality. The aim of 
this review was to assess avoidable waste in ophthalmic epidemiology by examining the availability 
of information from blindness prevalence surveys undertaken in LMICs between 2000 and 2014. 
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Methods 
Search strategy  
We sought to identify cross-sectional surveys of visual impairment and/or blindness undertaken in 
LMICs between the years 2000 and 2014. On December 1 2016 MEDLINE, EMBASE and Web of 
Science (2000 to November 2016) were searched without language restrictions using the algorithm 
‘blindness or vis* impairment or low vision’ and ‘prevalence or rapid assessment or population-
based’. To identify additional surveys to include, we examined reference lists of all articles selected 
for screening, as well as review articles of blindness prevalence.9-16 All surveys listed on the RAAB 
Repository website7 on December 1 2016 were reviewed. 
 
Study selection 
The titles of all citations identified during the initial search were systematically screened by two 
authors (JR and JK) to exclude publications that clearly did not meet the inclusion criteria. The full-
text article was retrieved for review if the citation was potentially relevant. All surveys listed on the 
RAAB Repository website7 on December 1 2016 were reviewed and for each eligible survey all 
available reports, tables and datasets were downloaded. 
 
Surveys were included that:  
(i) took place from January 2000 to December 2014; 
(ii) were conducted in countries classified by The World Bank as LMIC in 2014;17 
(iii) presented population-based data; and  
(iv) provided information on bilateral blindness prevalence. 
 
We excluded surveys that: 
(i) focused on specific populations (e.g. in hospitals, ‘institutionalised’, ‘diabetics’); 
(ii) only included children; 
(iii) presented self-reported blindness; or 
(iv) only presented the prevalence of disease-specific blindness without providing overall blindness 
prevalence data. 
 
If a survey report was published in two languages, the English version was assessed. 
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Data extraction and analysis 
For each survey included in the review the following items were extracted by one author (JR or WZ): 
the location, the year the survey concluded, the year it was published, and whether the RAAB 
protocol was used. We also recorded whether it was published in a scientific journal, and whether 
the journal was open-access on 1 December 2016. For RAABs, we recorded whether it was 
registered on the RAAB Repository, and whether a survey report, summary tables of results and the 
survey dataset had been uploaded to the Repository. 
 
Surveys were categorised as those  
i) only published in a scientific journal;  
ii) only with RAAB results tables on the Repository;  
iii) published and with RAAB results tables on the Repository; and  
iv) only registered on the Repository.  
 
Descriptive analysis included the proportion of studies that used the RAAB protocol; the proportion 
that were published and the lag-time to publishing from the time of the survey; the proportion making 
tables and datasets available; and the proportion published in an open-access journal.  
 
To assess variability of information available within surveys we extracted information on whether 
surveys reported blindness prevalence by one or both of:  
i) best-corrected and presenting visual acuity;  
ii) a cut-off of <3/60 and <6/60, the World Health Organization categories of blindness and severe 
visual impairment;  
iii) unilateral and bilateral;  
iv) the sample prevalence and the prevalence adjusted to the age and sex profile of the survey area; 
v) overall as well as disaggregated by sex.  
 
Finally, as a test of rigour, for the surveys that had two sources of information available (i.e. 
publication or survey report and RAAB tables) any discrepancy between the data reported in the two 
sources in relation to i) the number of participants, and ii) the sample blindness prevalence and 
confidence interval were noted. 
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Ethics exemption was granted for this literature review by from the London School of Hygiene & 
Tropical Medicine (Reference 10779). 
 
RESULTS 
Study selection 
A summary of study selection is presented in Figure 1. From the literature search a total of 4,818 
publications were identified for screening, including 24 identified from citation lists of screened 
publications. Following screening of titles and abstracts, 253 publications were identified for full 
review; the majority were in English, with 44 in Chinese, 9 in Spanish and none identified in other 
languages. After the initial assessment against the inclusion and exclusion criteria, 109 records were 
excluded for reasons provided in Figure 1. This left 144 publications—including 15 in Chinese and 
three in Spanish—reporting 156 separate studies for inclusion in this analysis. 
 
In addition to the literature search, the 266 RAAB surveys listed on the RAAB Repository on 
December 1 2016 were assessed against the inclusion and exclusion criteria. Of these, 76 were 
excluded for reasons provided in Figure 1, leaving 190 studies for inclusion in this analysis. Once 
duplicates appearing in both searches were removed, 279 separate studies were included in this 
analysis (listed in Supplemental Tables 1 and 2). 
 
Description of included studies 
The 279 studies were undertaken in 68 countries (Table 1) and two-thirds used either RAAB or 
RACSS protocol (n=186; 67%). Countries with the most studies were China (45), Vietnam (28), India 
(21), Bangladesh (14), Nepal (14) and Nigeria (14). One-quarter of LMICs with a population ≥20 
million (11/43) and 62% of LMICs with a population <20 million (58/93) had no study undertaken 
between 2000 and 2014 (Table 1). 
 
Published studies 
We identified 203 published studies: 165 in a scientific journal (in 153 manuscripts, including 72 
RAABs reported in 60 manuscripts) and 38 in a report of study methods and results available on the 
RAAB Repository. Seventeen of these studies (8%) sampled the whole country, while the remainder 
were limited to regions within countries (Table 2).  
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Information on when a study was completed was available for 188 of the published studies (93%). 
The time to publication ranged from <1 year (for study reports) to 11 years, with a mean and 
standard deviation of 2.8±1.8 years. Approximately half of the studies were published within two 
years (n=99; 49%) of study completion, and 85% of all studies were published within five years of 
study completion (172/203). The number of studies published increased over time, as did the 
proportion published in open-access journals (from 40% in 2000-4 to 57% in 2010-14; Table 2). 
 
RAABs 
Of the 186 RAABs, more than half (n=110; 59%) had published results (72 in scientific journals and 
38 in online reports). The remaining 76 studies (41%) only had information available on the 
Repository; twenty-three of these had RAAB summary tables and/or datasets available and 53 (28% 
of all identified RAABs) had no information available beyond registration on the Repository. 
 
Of the 53 RAABS where no information was available, 16 (30%) were conducted in the last 3 years, 
11 (21%) 4-5 years ago, and 26 (49%) more than 5 years ago. Studies without results available were 
most often conducted in Malaysia (n=5), Indonesia (n=5) and Vietnam (n=4) (Supplemental Table 2). 
Fifty RAABs (27%) had datasets available on the Repository. 
 
Available information within studies 
Table 3 shows reporting from the 226 surveys that were published and/or had RAAB tables 
available. Surveys with both RAAB tables and a study report available provided results for all five 
combinations of blindness definitions, while reporting was more variable for surveys that were 
published only (i.e. without summary results tables). Blindness prevalence was most commonly 
reported disaggregated by sex as well as overall (91%). Reporting both <3/60 and <6/60 cut-offs 
was also frequent (69%), followed by reporting both bilateral and unilateral blindness (67%), the 
sample and adjusted prevalence (60%) and finally, reporting best-corrected as well as presenting 
visual acuity (55%). The assessment for rigour showed discrepancies between the tables and 
publication for both outcomes—the number of participants and blindness prevalence differed 14% 
and 15% of the time respectively.  
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DISCUSSION 
To avoid waste, data from surveys should be summarised in a report which is made publicly 
available in a timely fashion, so that the results can be used by stakeholders for prioritising and 
planning future services. This review of blindness prevalence surveys undertaken between 2000 and 
2014 identified some good practices in relation to availability of information. For studies that were 
published, the majority achieved this within a reasonable time frame, and the proportion of studies 
available from open-access journals has increased (Table 2). The Repository provided an accessible 
infrastructure to track publication of registered surveys, as well as housing survey results, reports 
and datasets. The Repository also increased availability of study information and improved 
completeness of reporting through the provision of RAAB results tables (Table 3).  
 
This review also highlights where improvements can be made. First, survey reports remained 
unavailable for 1 in 5 of all identified RAABs [n=37] four or more years after study completion. These 
studies may yet be published in a scientific journal, but summary reports (and datasets) could be 
made available regardless, as demonstrated by the 23 unpublished studies with results tables 
available on the Repository. Failing to make a study report available is a waste of resources, and 
researchers must be accountable for the investment made by funding agencies, often using public 
resources. Unpublished research also has opportunity costs, including other research projects that 
could have been supported, and the services that members of the survey team—often eye health 
workers—could have delivered during time spent undertaking the survey. 
 
Second, we identified discrepancies in the range of blindness definitions reported (Table 3). The 
utility of survey findings would increase if comparable definitions were more consistently reported. 
Our findings reinforce the call for specific reporting guidelines to be developed for blindness 
prevalence surveys to ensure comparable information is collected and reported.18  
 
Third, the global coverage of surveys is unequal, with some countries having a high number of 
surveys relative to their population, while other countries have no information available from surveys 
(Table 1). A better distribution could be achieved if guidance is developed on how often a population 
based survey of eye health / visual impairment is required for what population size. 
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Fourth, only 1 in 6 studies (16%) provided full datasets. Whether researchers want to share data or 
not, the era of data sharing in epidemiology has arrived19 and is increasingly expected. Ophthalmic 
epidemiology has already seen the benefits of data sharing in syntheses to estimate global 
blindness9,12 and the incidence of vision-impairing cataract.20,21 Another benefit of data sharing is the 
improvement in data quality that occurs when it is known it will ultimately be shared.22 The 
discrepancies we identified between the datasets and published reports (Table 3) indicate the need 
for quality improvement in reporting of information. Beyond ensuring appropriate consent processes 
are in place, questions remain for implementation of data sharing, such as how to assure the quality 
of analyses arising from data sharing, and how to manage derived variables.19 The societal 
advantages of data sharing require stakeholders to address these questions rather than use them as 
an excuse for inaction, and fortunately guidance is emerging.22,23  
 
Our analysis must be interpreted in the context of its limitations. We were unable to assess non-
RAAB studies that have been completed yet remain unpublished, as there is currently no registration 
process or repository for these studies. Further, registration on the Repository is currently not 
compulsory for RAABs, so it is likely that there are completed RAABs which we did not identify. The 
registration role of the Repository can be further enhanced by promoting compulsory prospective 
registration (for instance, by it being a requirement for use of the RAAB survey tools, or before 
receiving funding).  
 
We were also unable to assess whether studies had been published locally and used for local 
planning, as no mechanism currently exists to measure this. It is possible some of the studies we 
categorised as unpublished have been summarised in reports not identified by our search. This 
information gap could be overcome in future if principal investigators reported to the Repository 
regarding how survey results were disseminated locally. While we performed our search without 
language restriction, it is likely that the databases we searched fail to index every study published in 
a language other than English.22,24 Finally, we did not contact researchers listed on the Repository to 
request the tables and datasets from their study or to find whether reports were available elsewhere. 
Doing so may have increased the proportion of studies for which information was available, but our 
results represent what is readily available and accessible.  
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Beyond increasing the availability of information, strategies are also required to increase the 
translation of research to policy and planning. Failing to analyse the results of prevalence surveys 
within the local context to inform planning and action is possibly the biggest (if currently unquantified) 
source of waste in ophthalmic epidemiology. Together with spending on prevalence surveys it is 
important that resources are also made available to translate the evidence into meaningful activities 
based on the results of the survey, and to do more intervention research to identify effective 
strategies to reduce blindness.25 
 
Investment in prevalence surveys in LMICs is set to continue in the pursuit of universal eye health.2 
Availability and quality of information from blindness prevalence surveys would improve if 
prospective registration of studies and availability of study reports and datasets becomes the 
expectation rather than the exception.26 The RAAB Repository facilitates study registration, full and 
consistent reporting of results and universal data access and in so doing provides a rare and 
valuable infrastructure27,28 to disseminate study information. We hope that this analysis promotes 
discussion amongst the ophthalmic community, increases the availability of study information, 
reduces avoidable waste from surveys and ultimately improves eye health. 
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Table 1: Blindness prevalence surveys undertaken in low and middle income countries 2000-2014 
Country 
World bank estimated 
2010 population 
(millions)* 
 Time period  
Total 
2000-4 2005-9 2010-14 
Countries <20 million     
Bhutan† 0.7 - 1 - 1 
Bolivia 9.9 - - 1 1 
Burkina Fasso 15.6 - - 1 1 
Burundi 9.5 - - 1 1 
Cambodia 14.4 3 1 1 5 
Cuba 11.3 - 1 1 2 
Dominican Republic† 9.9 - 1 - 1 
Ecuador† 14.9 - 1 - 1 
El Salvador† 6.0 - - 1 1 
Eritrea† 4.7 - 1 - 1 
Fiji 0.9 - 1 - 1 
Guatemala 14.7 1 - - 1 
Guinea Bissau 1.6 - - 1 1 
Honduras† 7.5 - - 1 1 
Jordan 6.0 - - 1 1 
Laos 6.3 - 1 - 1 
Liberia 4.0 - - 1 1 
Libya† 6.3 - - 1 1 
Malawi 14.8 - 1 1 2 
Mali 15.2 - 1 1 2 
Moldova† 3.6 - - 1 1 
Mongolia 2.7 - - 4 4 
OPT 3.8 - 1 - 1 
Panama† 3.6 - - 1 1 
Paraguay† 6.2 - 1 1 2 
PNG 6.8 - 1 - 1 
Rwanda 10.3 - 1 - 1 
Senegal 13.0 - - 2 2 
Sierra Leone 5.8 - - 1 1 
South Sudan 10.1 - 1 - 1 
Suriname 0.5 - - 1 1 
The Gambia 1.7 - 1 - 1 
Timor-Leste† 1.1 - 1 1 2 
Turkmenistan† 5.0 1 - - 1 
Zambia 13.9 - - 1 1 
Countries ≥20 million^     
Afghanistan 28.0 - - 3 3 
Bangladesh†† 151.6 1 4 9 14 
Brazil 198.6 2 1 - 3 
Burma 51.7 7 1 1 9 
China 1337.7 7 22 14 43 
Columbia 45.9 - 1 - 1 
Egypt 82.0 - 2 - 2 
Ethiopia†† 87.6 1 3 1 5 
Ghana 24.3 1 2 - 3 
India 1231.0 4 5 7 16 
Indonesia 241.6 3 1 3 7 
Iran 74.3 1 4 3 8 
Kenya 40.3 1 3 1 5 
Madagascar 21.1 - - 1 1 
Malaysia 28.1 1 - 6 7 
Mexico 118.6 - 1 2 3 
Mozambique 24.3 - - 2 2 
Nepal 26.9 1 11 2 14 
Nigeria†† 159.4 5 6 1 12 
North Korea 24.5 - - 1 1 
Pakistan†† 170.0 2 - - 2 
Peru 29.4 1 - 1 2 
Philippines 93.0 - 2 1 3 
South Africa 50.8 - 2 2 4 
Sri Lanka 20.7 - 1 - 2 
Sudan 36.1 - - 7 7 
Tanzania 45.6 - 2 - 2 
Thailand† 66.7 - - 1 1 
Uganda 33.1 - 1 3 3 
Vietnam 86.9 8 16 4 28 
Yemen 23.6 1 1 1 3 
Total  52 109 103 264^^ 
*downloaded from http://data.worldbank.org/indicator/SP.POP.TOTL [last updated 14/10/2015]; 
^32/43 (74%) LMICs with a population ≥20 million in 2010 had at least one survey undertaken between 2000 and 2014; the 11 countries ≥20 
million population without at least one survey were Algeria, Angola, Congo, Cote d'Ivoire, Iraq, Morocco, Romania, Syrian Arab Republic, 
Turkey, Ukraine, Uzbekistan; 
^^15 studies did not report the date of the survey and were not included in this table (India=5; Cameroon, China, Nigeria=2; Botswana, Kenya, 
Pakistan, Tanzania=1). (Botswana study sampled from the national population);  
† Includes at least one RAAB study that used a national sampling frame; 
††Includes at least one non-RAAB study that used a national sampling frame. 
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Table 2: Summary of included studies (blindness prevalence surveys in low and middle income 
countries 2000—2014) 
Description RAAB studies* 
Non- RAAB 
studies 
All studies 
Included Studies n=186 n=93 n=279 
Number of countries 63  
 
25 68 
Publication    
Scientific journal 
72 (39%) 
(in 60 manuscripts) 
93 (100%) 165 (59%) 
Online report 38 (20%) — 38 (14%) 
Not published 76 (41%) Unknown 76 (27%) 
Results Dissemination    
Published only 53 (28%)  93 (100%) 146 (52%) 
On Repository    
Published, datasets and results 
tables 
34 (18%) — 34 (12%) 
Published and results tables 23 (12%) — 23 (8%) 
Datasets and results tables 16 (9%) — 16 (6%) 
Results tables 7 (4%) — 7 (3%) 
Registered only  53 (28%) — 53 (19%) 
Published studies n=110 n=93 n=203 
National studies 12 (11%) 5 (5%) 17 (8%) 
Time to publication    
Unknown** 6 (5%) 9 (10%) 15 (7%) 
≤2 years 61 (55%) 38 (41%) 99 (49%) 
>2 years≤5 years 33 (30%) 40 (43%) 73 (36%) 
>5 years 10 (9%) 6 (6%) 16 (8%) 
Scientific Journals n=60 n=93 n=153 
Language    
English 54 (90%) 78 (84%) 132 (86%) 
Chinese — 15 (16%) 15 (10%) 
Spanish 6 (10%) — 6 (4%) 
Open-access (year published)†   
2000-4 0/2 (0%) 4/8 (50%) 4/10 (40%) 
2005-9 9/21 (43%) 19/35 (54%) 28/56 (50%) 
2010-14 20/33 (61%) 20/37 (54%) 40/70 (57%) 
* includes RACSS studies; 
**study completion date not given; 
†28 studies published after 2014 not included. 
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Table 3: Availability of information within included studies* (blindness prevalence surveys in low and 
middle income countries 2000—2014) 
 Availability of study information  
Total 
 
 
 
 Published Only RAAB Tables 
± Published ± 
Datasets**  RAAB 
Not 
RAAB 
 n=53 n=93 n=80 n=226^ 
Blindness definition % % % % 
Proportion of studies that report blindness 
in terms of both: 
   
 
Best-corrected and presenting visual acuity 26 33 100 55 
<3/60 and <6/60 cut-off 75 39 100 69 
Unilateral and bilateral visual acuity 47 51 100 67 
Sample and adjusted 60 26 100 60 
Overall and disaggregated by sex 83 87 100 91 
Rigour % (n)  
Proportion of studies with consistent 
results reported in RAAB tables and 
published report 
   
 
Number of participants - - 86 (49/57) - 
Blindness prevalence † - - 85 (47/55) - 
*53 studies registered on the RAAB Repository with no further information were not included in this table; 
** includes 57 studies that were published; 
† 2 studies did not report sample prevalence in the publication so this item could not be assessed. 
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